The government shutdown, stubborn inflation and a weak jobs market have yet to derail record stock market gains on Wall Street.
Author: techrossm
A ‘Fairly Highly Valued’ Market: A Fed Chair Opines On Stocks, But Should We Listen?
Here, I will try to explain why making the leap into concluding that stocks are in a bubble, and acting on that conclusion is
Stock Market Today: Dow Rises As Rocket Firms Soar; Nvidia-Musk Deal In Focus (Live Coverage)
Futures rose slightly with Nvidia reportedly investing in Elon Musk’s xAI. Rocket Lab and AST Space jumped on big news.
CZ Zhao-Backed YZi Labs Launches $1 Billion Fund To Boost BNB Chain Ecosystem
YZi Labs said its $1 billion builder fund is focused on BNB projects working on trading, real-world assets (RWAs), artificial intelligence (AI), decentralized science
YZi Labs entices founders to the BNB ecosystem with $1B Builder Fund
YZi Labs has committed a $1B Builder Fund to support founders in the BNB ecosystem, which has over 460 million users.
As dollar hits 2-month high, one strategist explains why ‘no news is good news’ for the greenback
The U.S. dollar tapped its strongest intraday level since the first half of August on Wednesday as a rebound rally in the world’s reserve
Stock Market News Today, 10/8/25 – U.S. Stock Futures Hold Steady Amid AI Bubble Fears and Surging Gold Prices
U.S. stock futures held steady early Wednesday as investors expressed concern over the potential artificial intelligence (AI) bubble. The S&P 500 …
Is BlackRock Equity Dividend R (MRDVX) a Strong Mutual Fund Pick Right Now?
Starting with BlackRock Equity Dividend R (MRDVX) is one possibility. MRDVX has a Zacks Mutual Fund Rank of 2 (Buy), which is based on
Antero Resources’ SWOT analysis: stock poised for LNG export boom
Antero Resources’ strategic decision to link a significant portion of its production to Gulf Coast pricing positions the company favorably in the current market
Karyopharm stock falls after announcing $100 million financing deal
Investing.com — Karyopharm Therapeutics (NASDAQ:KPTI) stock fell 13% after the commercial-stage pharmaceutical company announced strategic financing transactions that will provide $100 million in …